Mounjaro vs Ozempic for Weight Loss 2026: Which Works Better?

Two drugs now dominate the GLP-1 weight loss conversation: Ozempic/Wegovy (semaglutide) and Mounjaro/Zepbound (tirzepatide). Both are injectable GLP-1 medications, but they work slightly differently and produce different average results.

Here’s the complete comparison for 2026 — mechanism, efficacy, side effects, cost, and which telehealth providers offer each.

How They Work: GLP-1 vs. GLP-1 + GIP

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist — it mimics the GLP-1 hormone to reduce appetite, slow gastric emptying, and improve blood sugar regulation.

Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist — it activates both GLP-1 and GIP receptors simultaneously. GIP (glucose-dependent insulinotropic polypeptide) enhances the appetite-suppressing effects, which is why tirzepatide tends to produce greater weight loss on average.

Mounjaro vs Ozempic: Head-to-Head Comparison

Which Is More Effective?

The SURMOUNT-5 trial, which directly compared tirzepatide to semaglutide in head-to-head data, showed tirzepatide produced approximately 47% greater weight loss than semaglutide at comparable time points. In absolute terms, that’s typically an additional 5–7 lbs of weight loss over 12–18 months.

That said, individual response varies significantly. Some patients do extremely well on semaglutide, while others respond better to tirzepatide. Both are far more effective than older weight loss medications.

Cost Comparison: With and Without Insurance

Brand-name prices are similar for both drugs — prohibitive without coverage. The real cost advantage comes from compounded options available through telehealth providers:

• Compounded semaglutide: $179–$349/month through providers like Medvi, TrimRX, Brightmeds
• Compounded tirzepatide: $249–$449/month through providers like TrimRX

Which Should You Choose?

• Choose semaglutide (Ozempic/compounded) if: you want the most widely available option, you’ve seen good results with GLP-1s before, or you’re cost-conscious
• Choose tirzepatide (Mounjaro/compounded) if: you want maximum weight loss potential, you’ve tried semaglutide with limited results, or you have Type 2 diabetes with insurance coverage

Get Started with a Top GLP-1 Provider

Both medications are available through our top-rated telehealth providers. TrimRX offers both semaglutide and tirzepatide options:

Frequently Asked Questions

Making the Right Choice: Factors Beyond Weight Loss Numbers

While clinical trial data shows tirzepatide produces slightly greater average weight loss than semaglutide, choosing between Mounjaro and Ozempic involves several factors beyond the numbers alone. Insurance coverage varies significantly between the two medications, with some plans covering one but not the other. Your medical history also matters, as patients with type 2 diabetes may benefit from tirzepatide dual GIP/GLP-1 mechanism for superior blood sugar control. Side effect profiles differ slightly, with tirzepatide users reporting somewhat higher rates of gastrointestinal side effects during dose escalation. Injection frequency is the same for both at once weekly, but pen devices and available doses differ. Discuss these factors with your prescriber to determine which medication aligns best with your health goals, budget, and lifestyle preferences.

Disclosure: This article contains affiliate links. We may earn a commission if you purchase through our links, at no additional cost to you.